Fifth Third Bancorp Acquires 66,082 Shares of Teleflex Incorporated $TFX

Fifth Third Bancorp increased its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 3,204.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 68,144 shares of the medical technology company’s stock after buying an additional 66,082 shares during the period. Fifth Third Bancorp’s holdings in Teleflex were worth $8,151,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of TFX. Hsbc Holdings PLC boosted its stake in Teleflex by 4.7% in the first quarter. Hsbc Holdings PLC now owns 1,861 shares of the medical technology company’s stock valued at $222,000 after acquiring an additional 84 shares during the last quarter. Banque Cantonale Vaudoise grew its holdings in Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after acquiring an additional 113 shares during the period. Hantz Financial Services Inc. raised its position in shares of Teleflex by 40.5% during the 4th quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock valued at $48,000 after acquiring an additional 113 shares during the last quarter. UMB Bank n.a. lifted its stake in shares of Teleflex by 57.1% in the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after purchasing an additional 113 shares during the period. Finally, Maryland State Retirement & Pension System lifted its stake in shares of Teleflex by 1.5% in the 4th quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company’s stock valued at $1,056,000 after purchasing an additional 129 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Price Performance

TFX opened at $131.94 on Thursday. The stock has a market cap of $5.84 billion, a P/E ratio of -5.79, a P/E/G ratio of 0.97 and a beta of 0.82. Teleflex Incorporated has a 12 month low of $100.18 and a 12 month high of $139.67. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. The company has a fifty day simple moving average of $130.38 and a 200 day simple moving average of $120.30.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The firm had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. During the same period in the previous year, the company posted $1.44 earnings per share. The company’s revenue for the quarter was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, research analysts expect that Teleflex Incorporated will post 6.7 EPS for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date was Friday, May 22nd. Teleflex’s payout ratio is -5.96%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on TFX shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research note on Wednesday, June 24th. BMO Capital Markets began coverage on Teleflex in a research note on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 target price on the stock. Bank of America upgraded Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price on the stock in a report on Monday, April 13th. Mizuho boosted their target price on Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday. Finally, Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and upped their price target for the company from $135.00 to $155.00 in a research note on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $148.00.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.